PROFUND VP HEALTH CARE is a registered fund series of ProFunds (series S000003971). Net assets $29.8M as of 2026-03-31. Index fund.
Showing 15 of 134 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co. | — | $3.9M | 1323.42% |
| Eli Lilly & Co. | — | $3.9M | 1323.42% |
| Johnson & Johnson | — | $3.2M | 1069.73% |
| Johnson & Johnson | — | $3.2M | 1069.73% |
| AbbVie Inc. | — | $2.1M | 697.99% |
| AbbVie Inc. | — | $2.1M | 697.99% |
| Merck & Co., Inc | — | $1.6M | 542.15% |
| Merck & Co., Inc | — | $1.6M | 542.15% |
| UnitedHealth Group Inc. | — | $1.3M | 445.13% |
| UnitedHealth Group Inc. | — | $1.3M | 445.13% |
| Amgen Inc. | — | $1.0M | 344.07% |
| Amgen Inc. | — | $1.0M | 344.07% |
| Thermo Fisher Scientific Inc | — | $1.0M | 335.33% |
| Thermo Fisher Scientific Inc | — | $1.0M | 335.33% |
| Abbott Laboratories | — | $967K | 324.20% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $29.8M |
| 2025-12-31 | $34.6M |
| 2025-09-30 | $37.4M |
| 2025-06-30 | $30.7M |
| 2025-03-31 | $47.9M |
| 2024-12-31 | $32.8M |
| 2024-09-30 | $38.8M |
| 2024-06-30 | $37.7M |